Skip to main content
. 2012 Feb 22;2012:965956. doi: 10.1155/2012/965956

Table 2.

Prevalence of thoracic HRCT abnormalities in patients with AS according to disease duration.

Disease duration <5 yrs 5–10 yrs >10 yrs P
Number of patients at risk 50 18 23
Ground glass attenuation 9 (18) 2 (11.1) 4 (17.3) 0.855
Upper lobe fibrosis 3 (6) 2 (11.1) 5 (21.7) 0.049
Brochiectasis 9 (18) 1 (5.5) 5 (21.7) 0.881
Emphysema 11 (22) 3 (16.6) 8 (34.7) 0.309